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Ischemic Cranial Nerve III Palsy: Diagnosis, Management, and Follow-up
Abstract
Background: Acquired cranial nerve III palsies (CN3P) can be ischemic in nature due to underlying
vasculopathy, trauma, or by compressive damage due to aneurysm or tumor. In most cases,
neuroimaging is completed to rule out a life-threatening etiology. This case outlines an acute oculomotor
palsy due to ischemic microvascular disease with the appropriate diagnostic testing, treatment, and
follow-up course.
Case Report: A 67-year-old African American female presented with complaints of a drooping left eyelid
and intermittent diagonal diplopia. She had a known diagnosis of type 2 diabetes and hypertension.
Entering visual acuity was 20/25-1 in the right eye (OD) and 20/40-1 left eye (OS). No afferent pupillary
defect was noted OD or OS, however, a sluggish response to light was noted OS. Entrance testing was
unremarkable OD. CVF were restricted superiorly OS due to an incomplete ptosis and EOMs were
restricted in all gazes except abduction with the eye in a down-and-out position. The patient was sent to
the emergency room to rule out a pupil involving CN3P. All testing was unremarkable and a final diagnosis
of an ischemic CN3P was made.
Conclusion: Prompt diagnosis and neuroimaging is essential in the management of acute CN3P.
Clinicians must pay close attention to the pupils as it may reveal the etiology. In this case, the pupil
response warranted immediate referral to rule out potential life-threatening etiology. Fortunately, the
etiology was determined to be ischemia to the oculomotor nerve from her uncontrolled systemic
vasculopathies. Such patients should be monitored regularly until resolution.
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INTRODUCTION
An acquired cranial nerve III palsy (CN3P) can be ischemic in nature due to
underlying vasculopathy, trauma, or by compressive damage due to an aneurysm
or tumor. Assessing pupil function can be useful in deciphering aneurysmal versus
ischemic etiology. It is also important to recognize cases in which this cannot be
applied. In most cases, neuroimaging is completed to rule out a life-threatening
etiology. This case outlines an acute oculomotor palsy due to ischemic
microvascular disease with the appropriate diagnostic testing, treatment, and
follow-up course.
CASE REPORT
A 67-year-old African American female presented to the urgent care clinic with
complaints of pain around the left eye for one week. She reported pain spreading
from around the left orbit down to the left cheek. Three days prior, she had been
diagnosed with an abscess of the left jaw and was started on an unknown oral
antibiotic by her dentist. She noted associated blurry vision, intermittent “diagonal”
diplopia, and ptosis of the left eye (OS) for roughly two days prior to initial
presentation. Her last ocular examination, roughly three years prior, was
remarkable for presbyopia, incipient cataracts, and type 2 diabetes without
retinopathy or macular edema. The patient’s medical history was positive for
hypertension, hypercholesterolemia, and type 2 diabetes. She reported her last
blood sugar four days prior to presentation was 416 milligrams per deciliter
(mg/dL) after eating and her last hemoglobin A1c (HbA1c) five months prior as
roughly 9-10%. Systemic medications included rosuvastatin, pantoprazole sodium,
metformin hydrochloride, lisinopril- hydrochlorothiazide, Lantus®, and
Humalog®. She denied any history of surgeries or trauma and had no known
medical allergies. Family history was unremarkable. Social history was negative
for tobacco, alcohol, or recreational drug use. She wasoriented to person, place,
time, and her mood was appropriate.
Corrected distance visual acuities were 20/25-1 in the right eye (OD) and 20/401 OS. Distance pinhole acuity OS showed no improvement. Pupil measurements
were determined to be 3.5 mm OD and 4 mm OS in bright illumination and 4.5 mm
OD and 5 mm OS in dim illumination. Pupils were round and reactive to light OD
and OS, however, with a sluggish pupil response OS. No afferent pupillary defect
(APD) was noted OD or OS. Confrontation visual fields (CVFs) were full to finger
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count (FTFC) OD and constricted superiorly OS due to an incomplete ptosis. With
the upper eyelid lifted OS, CVFs were FTFC. Extraocular muscles (EOMs) were
unrestricted in all gazes OD, while eye movements OS were restricted in all gazes
except abduction with the eye in a down-and-out position. External examination
revealed an almost complete ptosis of the left upper eyelid (Figure 1).
Biomicroscopy revealed normal palpebral conjunctiva, bulbar conjunctiva, sclera,
puncta, and cornea in both eyes (OU) with 1+ meibomian gland dysfunction
(MGD) in both eyes. The anterior chambers were deep and quiet OD and OS, and
the anterior chamber angles were estimated Grade 4 by Van Herick estimation.
Iridies were flat and brown without neovascularization OU. Grade 1 nuclear
sclerotic cataracts were present in each eye. An undilated fundus examination
revealed a normal vitreous without posterior vitreous detachment OU. The optic
nerves were flat, sharp, well-perfused OU without neovascularization of the disc,
and the cup-to-disc ratio was 0.35 horizontal (H) /0.35 vertical (V) OU. There were
scattered paramacular dot hemorrhages present OU, without clinically significant
macular edema. Retinal arterioles were attenuated OU without signs of
neovascularization. The peripheral retinae were not viewed at this time as an
immediate referral to the emergency room was deemed necessary.

Figure 1: External photography at initial presentation showing an almost complete ptosis of theleft
upper eyelid with the left globe in a down-and-out position.

The differential diagnoses for this case included:
•

Cranial nerve III palsy – damage to the oculomotor nerve resulting in ocular
motility restrictions, ptosis, and possible pupil involvement on theaffected
side. CN3P can be congenital or acquired due several etiologies, including
vascular disorders, tumors, inflammation, or trauma.1

•

Myasthenia gravis – an autoimmune neuromuscular disorder responsible for
weakness of skeletal muscles including those responsible for chewing,
swallowing, facial expression, eye movements, and eyelid movements.
Patients typically note progressive muscle weakness worsened toward the
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•

•

•

end of the day or after periods of activity. Pupil involvement is not typically
observed. 2
Giant cell arteritis – an inflammation of medium sized arteries typicallyin
patients over 50 years of age. Vasculitis can lead to ischemia resulting in
patient symptoms including headache, jaw claudication, neck pain, scalp
tenderness, anorexia, malaise, and fever.3
Congenital ptosis – benign, abnormal drooping of the upper eyelid which
can be present at birth or occurs within the first year of life. Associated longterm sequelae can include deprivation amblyopia, anisometropia, and
cosmetic concerns for children.4
Superior orbital fissure syndrome – compression of structures just anterior
to the orbital apex which is most commonly a result of trauma. Clinical
findings include oculomotor, trochlear, and abducens nerve palsies, a fixed
and dilated pupil, proptosis, lacrimal hyposecretion, and loss of corneal
sensitivity. This condition does not result in optic nerve involvement.5

The patient denied a history of longstanding ptosis, nor progressive muscle
weakness that worsened toward the end of the day. The patient did not report any
jaw claudication, scalp tenderness, or headache, and no additional neurological
involvement was noted. Therefore, myasthenia gravis, giant cell arteritis,
congenital ptosis, and superior orbital fissure syndrome were considered as less
likely diagnoses. The patient was diagnosed with a complete cranial nerve III palsy
OS with concern for relative pupil involvement due to the sluggish response to light
OS.
An immediate referral to the emergency room was made to rule out lifethreatening compressive or vascular etiologies. Blood work was recommended
including complete blood count with differential, erythrocyte sedimentation rate,
C-reactive protein, fluorescent treponemal antibody absorption, and rapid plasma
regain to rule out infectious etiology. The patient was counseled on the importance
of strict blood sugar, blood pressure, and cholesterol control as her uncontrolled
systemic vascular health was highly suspected to be the underlying
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cause of her condition. A follow-up ocular examination was scheduled for six days.
She was advised to see her primary care physician within two weeks.
PHONE CALL #1

The patient was contacted for an update 1 day later by telephone. She stated that
she had been admitted into the hospital and a computerized tomography
angiography (CTA) as well as a magnetic resonance angiogram (MRA) had been
completed. The on-call ophthalmology resident reported that both the CTA and
MRA showed no signs of space-occupying lesions, aneurysms, or occlusive
vascular disorders and that all requested blood work had come back normal. He
stated that the patient was being held for close observation due to the ischemic
CN3P along with a concurrent oral abscess.
PHONE CALL #2

The patient called five days later (six days after initial onset) to report that she was
told her CN3P was caused by her “nerves not receiving enough blood.” She was
expected to be released from the hospital later that day with an eye patch to be worn
over her left eye. A follow-up had been scheduled by the hospital with their
neurology department 2 weeks after discharge.
FOLLOW-UP #1

The patient returned for follow-up as directed after discharge from the hospital 6
days following initial onset. She noted a now complete ptosis of the left upper
eyelid and “diagonal” diplopia with elevation of the upper eyelid. Her last blood
sugar was 233mg/dL earlier that day and her last HbA1c was 12.5% 1-day prior.
Corrected distance visual acuities were stable OU. The patient’s blood pressure was
130/70 mm Hg, right arm seated. Pupils, CVFs, and EOMs (Figure 2) were stable
OD and OS. Biomicroscopy revealed stable findings. Dilated retinal fundus
examination revealed stable findings of the posterior poles and unremarkable
peripheries. She was educated on the nature of the pupil- sparing CN3P with
anticipation of recovery within the next 3-6 months.
Additionally, the patient was educated on the presence of mild non-proliferative
diabetic retinopathy without macular edema OU and Stage 1 hypertensive
retinopathy OU. The importance of strict blood sugar, blood pressure, and
cholesterol control was emphasized. She was advised to follow-up with her
primary care physician and to return for monthly examinations until complete
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resolution. She was given the clinic’s 24-hour urgent care phone number and
advised to call immediately with any changes to vision or symptoms.

Figure 2: Extraocular motility pattern 6 days after initial onset of an ischemic, pupil sparing CN3P
OS showing a complete ptosis of the left upper eyelid with restricted supraduction, infraduction,
and adduction OS. Motility was unrestricted OD.

FOLLOW-UP #2

The patient returned 1 month later (2 months following initial onset) for
evaluation of the pupil-sparing ischemic CN3P OS. She reported stable complete
ptosis OS with diplopia when she lifted her upper eyelid. Her last blood sugar was
108mg/dL earlier that morning and her last HbA1c was 11% three weeks prior.
Corrected distance visual acuities were 20/30+2 OD and 20/30 OS. Distance
pinhole acuities were 20/25+2 OD, and 20/25-2 OS. Reduced best corrected visual
acuity OU was attributed to grade 1 nuclear sclerotic cataracts OD and OS. Pupil,
CVF, and EOM findings were stable. She was educated on the stability of her
condition and directed to return in 1 month for follow-up.
FOLLOW-UP #3

The patient returned 1 month later for follow-up (3 months following initial onset).
She reported stable complete ptosis OS and diplopia when the left upper eyelid was
lifted. Her last blood sugar was 101mg/dL earlier that morning. Corrected distance
visual acuities and all exam findings were stable. She was advised to return for
follow-up in 1 month.
FOLLOW-UP #4

The patient returned 1 month later for follow-up (4 months after initial onset). She
reported complete resolution of ptosis OS and denied any symptoms of diplopia,
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headache, or ocular pain. Her last blood sugar was 108mg/dL earlier that morning.
Corrected distance visual acuities, pupils, and CVFs were stable. EOMs were full
OD and OS without restrictions. Her upper eyelid positions were equal and
symmetric without ptosis OS (Figure 3). She was educated on the resolution of her
condition. The importance of blood sugar, blood pressure, and cholesterol control
were emphasized. She was directed to return for follow-up in 3months.

Figure 3: Extraocular motility pattern 4 months after initial onset of an ischemic, pupil-sparing
CN3P OS showed unrestricted motility OD and OS as well as a complete resolution of ptosis OS.

FOLLOW-UP #5

The patient returned for follow-up 3 months later (7 months after initial onset). She
reported stable symptoms and vision OU. She denied any recurrence of ptosis OS
and denied any symptoms of diplopia, headache, or ocular pain. Vision and all
exam findings were stable. She was educated on the stable ocular findings and
informed that she could begin to be monitored yearly with comprehensive eye
examinations. The importance of strict blood sugar, blood pressure, and cholesterol
control along with regular follow-up examinations with her primary care physician
were emphasized.
DISCUSSION
The oculomotor nerve (CN3) controls autonomic and somatic functions within the
orbit. The parasympathetic autonomic function of CN3 is responsible for the
innervation of the iris sphincter pupillae muscle and ciliary muscles controlling iris
constriction and accommodation. The somatic function of CN3 provides
innervation to the levator palpebral superioris muscle responsible for upper eyelid
elevation. Innervation of the superior rectus, medial rectus, inferior rectus, and
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inferior oblique muscles which are primarily responsible for elevation, adduction,
infraduction and extorsion respectively are also supplied by the somatic division of
CN3.1 The large somatic motor fibers run internally within CN3 while the small
autonomic parasympathetic fibers run externally.6 The spatial orientation of the
somatic and autonomic fibers within the oculomotor nerve provides insight into the
cause of a third nerve palsy-based pupil involvement.
A CN3P can be congenital or acquired. Congenital CN3Ps are typically caused by
malformation or raised intracranial pressure at the junction of the posterior
communicating artery (PCA) and internal carotid artery (ICA). Although
congenital CN3 is not life-threatening, it may indicate other congenital
malformations.1 Acquired CN3P can present as complete, incomplete, pupilsparing, pupil-involved, isolated, or complicated by additional neurologic
involvement. An incomplete, or partial, CN3P will present with a variable degree
of ptosis along with variable motility patterns depending on the affected extraocular
muscles. Incomplete CN3P are more common and may or may not have pupil
involvement. Complete CN3P are less common and present with a full
ptosis
and the affected eye in the down and out position due to complete damage to the
somatic function. As with a partial CN3P, pupil involvement may or may not be
present in a complete CN3P.7 Pain associated with a CN3P cannot be used to
determine ischemic or compressive etiology as both present with essentially equal
frequency.8
The majority of isolated CN3P are caused by microvascular abnormalities due to
underlying vascular diseases including hypertension, diabetes, or hyperlipidema.9
Damage to the oculomotor nerve associated with microvascular disease leads to
ischemia of the internal somatic motor fibers causing ptosis and extraocular
motility restrictions classically without affecting pupillary function. Compressive
damage to the oculomotor nerve causes ischemia to the external autonomic fibers
resulting in painful pupillary involvement in the form of a fixed, non-reactive pupil
with associated ptosis and motility restrictions. While pupil involvement is a strong
predictor of compression by an aneurysm at the junction of the PCA and ICA, it
does not rule out microvascular cause. It has been reported that 14-32% of ischemic
and 64-86% of compressive CN3P present with pupil-involvement.9,10 Research
has shown that 14% of CN3P caused by an aneurysm at the junction of the ICA and
PCA present initially without pupil involvement and eventually progress to pupil
involvement within 7-10 days.8 Therefore, a lack of pupil involvement on initial
presentation should not rule out aneurysmal or compressive etiology.6,9
There is also a “Rule of the Pupil” in association with CN3P first described by
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Rucker in 1958.11 These guidelines proposed that if a CN3P occurs without pupil
involvement, it is highly suggestive of ischemic microvascular disease. On the
other hand, he observed that the majority of pupil-involved CN3P were due to an
aneurysm. The close proximity of the external autonomic fibers within the
oculomotor nerve to the PCA and ICA results in compression of these fibers first
in the case of a PCA or ICA aneurysm. Rucker’s rule states that up to 97% of pupilinvolved CN3P are caused by aneurysm.10
However, the “Rule of the Pupil” should not be applied in the following situations.
First, in patients between twenty to fifty years of age in which advanced
microvasculardisease is unlikely. These cases must be worked-up as an aneurysm
until proven otherwise and microvascular etiology considered a diagnosis of
exclusion.
Second, an incomplete CN3P has been shown more often to be caused by a slow
growing aneurysm and, therefore, should be diagnosed as an aneurysm until proven
otherwise. It has been documented that roughly 14% of all carotid aneurysms
initially present as pupil-sparing incomplete CN3P.10,11 The third instance in which
this rule should not be followed is in the case of a CN3P with relative pupil sparing.
In these patients, the affected pupil does react, however, not to the same extent as
the unaffected pupil. This sluggish pupil response on the affected side is referred to
as “relative” pupil-sparing. The final occasion in whichthe “Rule of the Pupil” is
inappropriate to follow is a case of a complicated CN3P. If other neurologic
symptoms including, but not limited to, an abduction deficit, facial weakness,
proptosis, or loss of corneal sensitivity are observed in association with a CN3P
regardless of pupil involvement, further work-up and imaging is necessary.10
In clinical practice, neuroimaging is often completed on patients presenting with
an acute CN3P regardless of pupil involvement due to the potential risk of death
associated with rupture of an aneurysm. Use of neuroimaging is necessary in the
four abnormal clinical presentations listed above in which the “Rule of the Pupil”
cannot be applied.12 An imaging technique known as digital subtraction
angiography (DSA) is considered the gold standard in the detection of an
intracranial aneurysm. This modality removes all structures other than blood
vessels from the image to make blood vessels more visible. However, due to the
risk of stroke associated with this technique, DSA has generally been replaced with
less invasive imaging techniques.8 The most common imaging techniques currently
used for CN3P include CTA and MRA.8 In the majority of patients, both imaging
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studies will be performed. In the case of a CN3P, CTA is often more sensitive in
the detection of an intracranial aneurysm versus MRA. One possible hindrance of
CTA is the potential for an aneurysm to be masked by nearby bony details. In this
instance, an MRA would be considered superior. An additional benefit of an MRA
is the lack of patient exposure to ionizing radiation as seen with a CTA.8
An uncommon but well documented phenomenon associated with CN3P due to
aneurysm, trauma, or tumors is aberrant regeneration of the oculomotor nerve.
This condition is also known as oculomotor synkinesis and occurs in roughly 15%
of acquired CN3P.13 In most instances, the oculomotor nerve will spontaneously
regenerate without any complications. However, in some cases the nerve does not
fully regenerate, and its axons become misdirected allowing for inappropriate
innervation of different muscles.14 There is no clear way to determine which
patients will go on to develop aberrant regeneration. However, cases of CN3P due
to microvascular disease never result in synkinesis.15 There are three typical
patterns of oculomotor synkinesis. The first, referred to as Pseudo Von-Graefe’s
Sign, presents as upper eyelid elevation with down-gaze. This phenomenon is
caused by axonal misdirection from the inferior rectus to the ipsilateral levator
palpebral superioris muscle.16 Another form of oculomotor synkinesis occurs due
to misdirection of axons from the medial rectus to the levator palpebral superioris
muscle resulting in upper eyelid retraction with adduction. Pupil constriction upon
adduction has also been documented due to aberrant connections between the axons
of the medial rectus and iris sphincter muscle.14
After a systemic evaluation has been completed and aneurysmal or compressive
etiologies have been excluded, regular follow-up is necessary. It is recommended
that patients be followed every month for at least 6 months until resolution has been
reached. If complete resolution is not seen by 6 months, further improvement can
be expected up to one-year post onset.17 With a complete ptosis, diplopia is
typically not a concern. However, as the ptosis begins to improve, diplopia may be
noted, and occlusion therapy may be necessary. If photophobia secondary to a
dilated pupil is a concern, pilocarpine drops may be used for management.17
Conclusion
This case demonstrates the typical presentation, work-up, and management of a
CN3P due to underlying vascular disease. In all patients presenting with an acute
CN3P, it is important to pay close attention to the pupils. Using the “Rule of the
Pupil” can play an important role in deciphering aneurysmal versus ischemic
etiology. It is also important to recognize cases in which this cannot be applied. In
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this case, the slight anisocoria with the sluggish pupil response warranted
immediate referral for imaging to rule out potential aneurysmal or compressive
etiology. Neuroimaging with MRI or CTA is done on many patients with acute
CN3P to rule out the potential risk of stroke or death by rupture of an intracranial
aneurysm. Fortunately, no such cause was found and this patient’s CN3P was
determined to be caused by ischemia to the oculomotor nerve from her history of
uncontrolled hypertension and type 2 diabetes. As demonstrated in this case,
aberrant regeneration of the oculomotor nerve is not seen in cases of ischemic
CN3P. However, in CN3P caused by tumor, aneurysm, or trauma, incomplete
recovery may occur, and misdirection of the axons may be seen causing abnormal
motility or pupil patterns. As seen in this case, it is important to monitor these
patients regularly for up to 6 months until resolution is observed. If complete
resolution is not seen at 6 months, further improvement may be appreciated up to 1
year.
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